Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2018-06-07 Sale | 2018-06-11 6:00 pm | Loxo Oncology Inc. | LOXO | Flaherty Keith T. Director | 50,000 | $173.54 | $8,677,027 | 42,077 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-06-13 Option Award | 2022-06-15 5:01 pm | N/A 2032-06-13 | Kinnate Biopharma Inc. | KNTE | Flaherty Keith T. Director | 20,250 | $0 | 20,250 (Direct) | View |
| 2022-05-31 Disposition | 2022-05-31 10:12 am | N/A 2031-06-16 | Checkmate Pharmaceuticals Inc. | CMPI | Flaherty Keith T. Director | 36,778 | $0 | 0 (Direct) | View |
| 2021-06-16 Option Award | 2021-06-21 9:24 pm | N/A 2031-06-16 | Checkmate Pharmaceuticals Inc. | CMPI | Flaherty Keith T. Director | 10,030 | $0 | 10,030 (Direct) | View |
| 2021-06-11 Option Award | 2021-06-14 7:13 pm | N/A 2031-06-11 | Kinnate Biopharma Inc. | KNTE | Flaherty Keith T. Director | 20,250 | $0 | 20,250 (Direct) | View |
| 2021-06-10 Option Award | 2021-06-11 9:02 pm | N/A 2031-06-10 | Clovis Oncology Inc. | CLVS | Flaherty Keith T. Director | 42,223 | $0 | 42,223 (Direct) | View |
| 2020-12-02 Ownership | 2020-12-02 9:11 pm | N/A N/A | Kinnate Biopharma Inc. | KNTE | Flaherty Keith T. Director | 0 | $0 | 165,944 (Direct) | View |
| 2020-08-06 Ownership | 2020-08-06 9:04 pm | 2020-03-27 2028-03-27 | Checkmate Pharmaceuticals Inc. | CMPI | Flaherty Keith T. Director | 0 | $0 | 26,748 (Direct) | View |
| 2020-06-04 Option Award | 2020-06-05 5:03 pm | N/A 2030-06-04 | Clovis Oncology Inc. | CLVS | Flaherty Keith T. Director | 40,138 | $0 | 40,138 (Direct) | View |
| 2019-06-06 Option Award | 2019-06-07 4:45 pm | N/A 2029-06-06 | Clovis Oncology Inc. | CLVS | Flaherty Keith T. Director | 28,882 | $0 | 28,882 (Direct) | View |
| 2019-02-15 Disposition | 2019-02-15 09:11 am | N/A 2023-12-16 | Loxo Oncology Inc. | LOXO | Flaherty Keith T. Director | 208,155 | $235 | 0 (Direct) | View |
| 2018-10-11 Option Award | 2018-10-15 6:50 pm | N/A 2028-10-11 | Clovis Oncology Inc. | CLVS | Flaherty Keith T. Director | 14,770 | $0 | 14,770 (Direct) | View |
| 2018-06-13 Option Award | 2018-06-14 5:02 pm | N/A 2028-06-12 | Loxo Oncology Inc. | LOXO | Flaherty Keith T. Director | 8,750 | $0 | 8,750 (Direct) | View |
| 2018-06-07 Exercise | 2018-06-11 6:00 pm | N/A 2023-12-16 | Loxo Oncology Inc. | LOXO | Flaherty Keith T. Director | 50,000 | $0 | 42,077 (Direct) | View |
| 2018-06-07 Exercise | 2018-06-11 6:00 pm | N/A N/A | Loxo Oncology Inc. | LOXO | Flaherty Keith T. Director | 50,000 | $1.184 | 42,077 (Direct) | View |